Alzheimer's Disease
Quest announces availability of blood-based Alzheimer’s test
Quest Diagnostics has announced the availability of a blood-based test that assesses the risk of developing Alzheimer’s disease through amyloid-beta biomarkers.
AAN guidance on early AD treatment focuses on care, collaboration, new therapies
New guidance from the American Academy of Neurology on early Alzheimer’s disease treatment calls for greater collaboration from patients, caregivers and clinicians as well as the embrace of new therapeutics.
Firms hope partnership advances access to blood-based Alzheimer’s testing
A partnership between a clinical diagnostics company and a clinical manufacturing firm aims to support therapeutic development, clinical trials, reimbursement and routine clinical adoption for a range of neurodegenerative diseases.
New county-level Alzheimer’s estimates may help allocate resources
New county-level estimates of Alzheimer’s prevalence released at the Alzheimer’s Association International Conference may help inform allocations of funding, staffing and other resources toward caring for patients.
BLOG: Primary eye care will screen for Alzheimer’s disease in the future
Fifty million people worldwide and 6.7 million Americans are currently living with Alzheimer’s disease. Unfortunately, I know firsthand the suffering this disease can cause.
Finger prick test detects blood-based biomarkers of Alzheimer’s disease
A finger prick test measured blood-based biomarkers of Alzheimer’s disease and has potential to increase accessibility of testing, according to research at the Alzheimer’s Association International Conference.
Bowel movement frequency, gut microbiome linked to cognitive function
Chronic constipation was associated with worse cognitive function, equal to 3 years of additional aging, according to research presented at the Alzheimer’s Association International Conference.
Blood tests for AD pathology may improve diagnostic accuracy, treatment in primary care
Utilization of blood tests to detect Alzheimer’s pathology may boost diagnostic accuracy and treatment in a primary care setting, according to research presented at the Alzheimer’s Association International Conference.
Draft revision of Alzheimer’s diagnostic criteria includes blood-based biomarkers
A draft proposal for new Alzheimer’s disease diagnostic criteria incorporates blood-based biomarkers, whose utility, relatively low cost and performance have made them a promising new tool in AD detection.
Attention, memory deficits greater in Caribbean Hispanic adults with cognitive decline
Older Caribbean Hispanic individuals with mild cognitive impairment scored lower on measures of attention and working memory compared with non-Hispanic white counterparts, according to researchers.